Nigel has 30 years’ experience in the pharmaceutical industry where he developed expertise in commercialisation, pipeline development, and product launches.
During 17 years at GSK, Nigel held global, regional, and in-country leadership positions in commercialisation and strategy, working on assets from early development through to launch and lifecycle expansion. He also spent time leading global launch & marketing excellence focussed on launch preparation, execution and optimising in market launch performance. Most recently he served as VP Portfolio Strategy, China, responsible for securing multi-million-dollar, board level investments to fast-track the launch of the entire GSK pipeline into the China market. He also established GSK China’s oncology business unit.
Prior to GSK, he spent 10years with BMS in key commercial roles, culminating in leadership positions focused on sales and marketing of established assets and the launch of multiple new medicines.
Most recently Nigel has been working with bio-tech, med-tech and pharma companies on creating commercial value from early development through to launch, go-to-market launch planning and commercial optimisation strategies across the post-launch lifecycle.
Nigel holds an MBA from London Business School and a BSc in Medicinal Chemistry from the University of Newcastle upon Tyne.
